Velasof is a prescription medicine used for the treatment of chronic hepatitis C virus (HCV) infection. It is a combination of Velpatasvir and Sofosbuvir, both of which are antiviral drugs. Velasof works by preventing the virus from multiplying and spreading in the body.
Each tablet of Velasof contains Velpatasvir 100 mg and Sofosbuvir 400 mg as its active ingredients. The tablet also contains inactive ingredients such as lactose monohydrate, croscarmellose sodium, magnesium stearate, and microcrystalline cellulose.
Velasof is used for the treatment of chronic hepatitis C virus (HCV) infection in adults. It may be prescribed for patients who have not been treated previously or for those who have not responded to previous treatment. Velasof can be used for patients with or without cirrhosis.
HOW TO USE:
Velasof should be taken orally, once daily, or as directed by your healthcare provider. The tablets can be taken with or without food, but it is recommended to take them at the same time each day. Do not crush or chew the tablets, swallow them whole. It is important to complete the full course of treatment as prescribed by your doctor.
The recommended dosage of Velasof is one tablet taken once daily for 12 weeks. The duration of therapy may vary depending on the patient’s medical condition and response to treatment. The tablets should not be split, crushed, or chewed.
Velasof tablets should be stored at room temperature, away from heat and moisture. They should be stored in their original packaging and should not be exposed to direct sunlight. Keep the medicine out of reach of children.
Mechanism of Action:
Velasof works by inhibiting the replication and spread of the hepatitis C virus in the body. Sofosbuvir interferes with the HCV RNA replication process, while Velpatasvir inhibits the viral protein NS5A, which is essential for viral replication.
Before taking Velasof, inform your doctor about any medical conditions you have or medicines you take, including vitamins and herbal supplements. This medicine is not recommended for pregnant or breastfeeding women. It is also not recommended for patients with severe kidney or liver disease.
Velasof is contraindicated in patients who are allergic to any of its ingredients. It should not be used in combination with other drugs that contain Sofosbuvir or Velpatasvir.
Velasof may interact with other drugs, including rifampin, carbamazepine, and St. John’s wort. Inform your doctor about all the medicines you are taking.
In case of an overdose, seek emergency medical attention immediately. Overdose symptoms may include nausea, vomiting, diarrhea, and headache.
Common side effects of Velasof include headache, fatigue, nausea, diarrhea, and insomnia. If any of these side effects become severe or persistent, inform your doctor. Serious side effects may include symptoms of liver problems, such as yellowing of the skin or eyes, or abdominal pain. Seek medical attention immediately if you experience any severe side effects.